Evidence mapPaperPMID 40465749Full record

ArticlePloS one2025

Quality of insulin obtained from hospital and community pharmacies in Mwanza Tanzania: A cross-sectional study.

Emmanuel Kimaro, Eveline T Konje, Benson R Kidenya, Amani T Mori, Eliangiringa Kaale

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emmanuel KimaroCatholic University of Health and Allied Sciences (CUHAS), School of Pharmacy, Department of Pharmaceutics and Pharmacy Practice, Mwanza, Tanzania.ORCID https://orcid.org/0000-0003-3123-0477
Eveline T KonjeCatholic University of Health and Allied Sciences (CUHAS), School of Public Health, Department of Biostatistics, Epidemiology and Behavioral Sciences, Mwanza, Tanzania.
Benson R KidenyaCatholic University of Health and Allied Sciences (CUHAS), Weill Bugando School of Medicine, Department of Biochemistry and Molecular Biology, Mwanza, Tanzania.
Amani T MoriDepartment of Global Public Health and Primary Care, Section for Ethics and Health Economics, University of Bergen, Bergen, Norway.
Eliangiringa KaalePharm R&D Laboratory, School of Pharmacy, Muhimbili University of Health and Allied Sciences (MUHAS), School of Pharmacy, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0001-6008-3539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsulin, a peptide hormone crucial for diabetes management, necessitates strict storage (2-8oC) to maintain concentration, as per regulatory guidelines (e.g., USP, WHO). Degradation can occur during manufacturing process, and transportation or storage, via heat-induced denaturation and aggregation, compromises its efficacy. In Sub-Saharan Africa, including Tanzania, weak regulatory oversight of imported medicines may compromise insulin quality. Varied findings from existing studies underline the need for local quality assessments.

methodsThis cross-sectional study, conducted from April to July 2024 in Mwanza, Tanzania, evaluated the quality of insulin from eight pharmacies. A convenience sampling approach was employed, with insulin samples purchased as a simulated patient to reflect real-world acquisition. 15 samples, representing seven distinct insulin brands, were collected. High-Performance Liquid Chromatography (HPLC) was utilized to quantify insulin concentration. Additionally, samples were assessed for visual appearance, packaging, labeling, and storage conditions following established pharmacopoeial and quality control standards.

resultsOut of 15 insulin samples, two samples (13.3%) failed to meet the official USP monograph during the assay test. The remaining samples 13 (86.7%) complied with USP standards.

conclusionThese findings underline significant challenges in ensuring the quality of insulin products. While most samples adhered to USP standards, the issues observed highlight the need for improved quality control measures and robust cold chain management to guarantee the efficacy and reliability of insulin for diabetic patients.

Indexed as

Hypoglycemic AgentsInsulinPharmaciesChromatography, High Pressure LiquidCross-Sectional StudiesDrug StorageHumansQuality ControlTanzaniaHypoglycemic AgentsInsulin

Identifiers

PMID40465749
PMCPMC12136432

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.